A world leader in the development and commercialization of innovative Light Accelerated Orthodontic products.
Focused on innovating genetic analysis tools for the research and diagnostics market.
Targeting inflammation in cardiovascular and renal disease.
The future of microbiome therapeutics.
Leader in the discovery and development of novel therapeutics based on the biology of DNA repair and synthetic lethality for the treatment of cancer and autoimmune diseases.
The first clinically-proven treatment to safely and sustainably reverse type 2 diabetes without medications or surgery.
Inscripta offers the world’s first benchtop platform for scalable Digital Genome Engineering to address the current challenges and limitations of gene editing.
Harnessing the regulatory genome to create next-generation molecular therapies.
Unity Biotechnology is designing therapeutics that prevent, halt or reverse numerous diseases of aging.